MyFinsight
Home
About
Contact
Back
Income Statement
Coeptis Therapeutics Holdings, Inc. (COEP)
source: myfinsight.com
Download
Download image
Net loss
-$1,828,914
(71.20%↑ Y/Y)
Net income (loss),
including portion...
-$1,828,914
Change in fair value of
derivative liability...
$349,500
Other income
(expense)
$51,558
(318.46%↑ Y/Y)
Income (loss) from
continuing operations...
-$1,828,914
(71.20%↑ Y/Y)
Nonoperating income
(expense)
$312,875
(-80.08%↓ Y/Y)
Disposal group, not
discontinued operation, loss...
$37,257
Interest expense,
nonoperating
$50,926
Operating income (loss)
-$2,141,789
(72.96%↑ Y/Y)
Operating expenses
$2,141,789
(-72.96%↓ Y/Y)
Amortization expense
$250,000
General and
administrative expenses
$173,073
(-93.85%↓ Y/Y)
Professional services
expense
$431,304
Research and development
expense
$811,784
(-84.00%↓ Y/Y)
Salary expense
$378,740
Share based
compensation
$96,888
Back